The AI Procurement Challenge in Healthcare
Artificial intelligence adoption in healthcare is no longer aspirational—it is operational reality. From diagnostic imaging algorithms to predictive analytics platforms, health systems are integrating AI solutions at unprecedented velocity. Yet cybersecurity due diligence has not kept pace with procurement velocity. The Healthcare Information and Management Systems Society (HIMSS) 2024 report found that 67% of healthcare organizations lack formal security assessment processes for AI vendors, creating significant risk exposure under HIPAA Security Rule §164.308(a)(3), which explicitly requires covered entities to evaluate and manage information system risks.
CISOs and compliance officers bear the responsibility of ensuring AI vendors meet organizational, regulatory, and clinical safety standards. This checklist provides 12 actionable questions grounded in established frameworks including the NIST Cybersecurity Framework (CSF), FAIR risk modeling, CIS Controls v8, and HITRUST CSF—standards recognized by OCR during breach investigations and compliance audits.
The 12 Essential Procurement Questions
1. Does Your AI Model Governance Include Documented Version Control and Training Data Provenance?
Require vendors to provide a software bill of materials (SBOM) for AI components, including training datasets, model versions, and update procedures. This aligns with NIST CSF ID.AM-5 (asset inventory) and supports your ability to assess model drift, retraining frequency, and potential bias introduction. Ask specifically: "What is your model versioning scheme, how frequently is retraining performed, and how do you document changes to training data?"
2. What Penetration Testing, Vulnerability Scanning, and Third-Party Security Assessments Has the Vendor Completed?
Require evidence of annual penetration testing and vulnerability assessment reports from independent firms. HIPAA Security Rule §164.308(a)(1)(ii)(B) mandates periodic security reviews. Request HITRUST CSF certification or equivalent validation. Do not accept vendor self-assessments alone. Establish contractual language requiring right-of-audit and annual security assessment updates.
3. How Does the Vendor Implement Data Minimization for PHI Within AI Model Training and Inference?
AI models often require extensive PHI exposure during training and validation. Challenge vendors on de-identification protocols, differential privacy implementation, and federated learning architectures that minimize direct PHI exposure. NIST CSF PR.DS-1 (data protection) emphasizes minimizing data handling. Ask: "Can you achieve inference-time accuracy without retaining PHI post-deployment?"
4. What Is Your Incident Response and Breach Notification Protocol?
Define contractual obligations for incident notification (target: within 24 hours of discovery), breach assessment, impact analysis, and regulatory reporting support. Clarify whether the vendor assumes breach notification responsibility or whether your organization retains full liability. This is non-negotiable under HIPAA §164.400–414.
5. How Do You Ensure Model Explainability and Clinical Interpretability?
Especially for clinical decision-support AI, require documentation of explainability mechanisms—SHAP values, attention visualizations, or other interpretable outputs. The FDA's 2023 guidance on AI/ML in medical devices emphasizes transparency. Confirm clinicians can understand why the model generated a specific recommendation, supporting safe clinical integration and liability defense.
6. Does Your Vendor Maintain SOC 2 Type II Certification and What Are Your Audit Results?
SOC 2 Type II audits (covering security, availability, processing integrity, confidentiality, and privacy) provide structured evidence of operational controls. Request reports covering at least 6 months of audit activity. Evaluate findings and remediation timelines. This aligns with HITRUST CSF requirements and demonstrates commitment to CIS Controls v8 (e.g., AS 6.1, Detection and Analysis).
7. What Contractual Liability Caps and Cybersecurity-Specific Indemnification Will You Accept?
Negotiate liability frameworks that address AI-specific harm (e.g., algorithmic bias causing patient harm, data breach via model theft). Standard vendor limitation-of-liability clauses are often unacceptable for healthcare. Require vendors to carry cyber liability insurance ($5M–$10M minimum) and provide proof of coverage naming your organization as additional insured.
8. How Do You Handle Model Robustness Against Adversarial Attacks and Poisoning?
Ask vendors for evidence of adversarial testing and robustness validation against input manipulation, model extraction attacks, and poisoning scenarios. This reflects NIST CSF RC.IM-1 (incident mitigation) and emerging AI-specific security standards. Require documentation of attack surface analysis specific to your use case.
9. What Is Your Data Residency, Encryption, and Access Control Architecture?
Clarify where PHI is stored (on-premises, cloud region, third-party infrastructure), encryption status (in transit and at rest), and access logging. HIPAA Security Rule §164.312(a)(2) requires encryption and access controls. Require encrypted communication channels, role-based access control (RBAC) aligned with your HIPAA minimum necessary principle, and comprehensive audit logging queryable by your team.
10. What Is Your Vendor's Subcontractor and Supply Chain Risk Management Process?
Many AI vendors rely on cloud infrastructure providers, data labeling services, or model repositories that introduce transitive risk. Require a complete list of subcontractors and their own security certifications. Confirm Business Associate Agreements (BAAs) are in place for all entities touching PHI. This aligns with NIST CSF GOVERN and SUPPLY CHAIN RISK MANAGEMENT functions.
11. Can You Provide a Comprehensive Data Processing Addendum (DPA) Aligned With HIPAA?
Standard Data Processing Addenda from tech vendors often lack healthcare-specific provisions. Require a HIPAA-aligned DPA covering data inventory, permitted uses, breach notification obligations, sub-processor management, and data deletion protocols. Your legal and compliance teams should review alongside your CISO assessment.
12. What Is Your Governance Process for Detecting and Remediating Algorithmic Bias and Performance Drift?
Require evidence of continuous monitoring dashboards tracking model performance across demographic subgroups, ongoing drift detection, and defined remediation thresholds. Document the vendor's commitment to bias assessment aligned with emerging standards (NIST AI Risk Management Framework). Establish contractual performance guarantees and audit rights.
Operationalizing the Checklist
Integrate these 12 questions into a standardized vendor assessment scorecard weighted by criticality. Use FAIR methodology to quantify risk: if a vendor lacks SOC 2 certification and breach notification protocols, calculate the probability and impact of undetected compromise to inform risk acceptance decisions. Document all findings in your vendor risk register, establish monitoring cadences, and define re-assessment intervals (annually minimum for critical AI systems).
This procurement discipline protects patient safety, ensures regulatory compliance, and builds organizational resilience in an era of rapidly evolving AI risk.